CVE-2026-127420: Oracle VM VirtualBox · Easily exploitable vulnerability allows unauthenticated attacker with logon to the infrastructure
Affects Oracle VM VirtualBoxSource CVE Database V5
Not known to be exploited · CVSS 4.4 Medium.
Data as of 17 Nov 2026, 22:22 UTC
Thin evidence
One scorer or none| CNA (oracle) | CVSS 3.1 | 4.4 |
|---|
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 17 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 17 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Oracle CorporationOracle VM VirtualBox | Affected
| Fixed in– |
AI-suggested
Oracle recommends applying the security patches included in the November 2026 Critical Security Patch Update. Customers should ensure they are running actively supported versions and apply available patches without delay. The vendor advisory does not explicitly state if a patch for version 7.2.22 is available, so users should consult the Oracle advisory directly for patch status and installation instructions. No alternative mitigations or workarounds are provided.
Description
CVE-2026-127420 is a vulnerability in Oracle VM VirtualBox version 7.2.22 that allows an unauthenticated attacker with logon access to the infrastructure to compromise the product. Exploitation requires user interaction from someone other than the attacker. Successful exploitation can lead to unauthorized read, update, insert, or delete access to some data accessible by Oracle VM VirtualBox. The vulnerability has a CVSS 3.1 base score of 4.4, indicating medium severity with limited confidentiality and integrity impacts.